TITLE

On Chemical Imbalances, Antidepressants, and the Diagnosis of Depression

AUTHOR(S)
Leventhal, Allan M.; Antonuccio, David O.
PUB. DATE
November 2009
SOURCE
Ethical Human Psychology & Psychiatry;2009, Vol. 11 Issue 3, p199
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Over the past 30 years psychiatry has made a paradigm shift within a medical model from a psychological to a biological explanation for mental disorder. Depression is attributed to an imbalance of monoamines in the brain caused by depletion of neurotransmitters at receptor sites. The standard of care for treating depression is prescription of antidepressant medications alleged to correct this chemical imbalance. Research results testing the chemical imbalance theories for depression have been contradictory to the theories. Analyses of data from studies and meta-analyses of the efficacy of antidepressants indicate selective publication fostering an inflated impression of effectiveness and that antidepressants offer little more than placebos. Several sources of error, particularly breaking of the blind, may have determined outcome in studies showing drug/placebo differences. Despite negative results regarding the theory and pharmacotherapy for depression, the frequency of diagnoses of depression and prescription of antidepressant drugs have increased enormously. Economic interests more than science appear to be determining the treatment of depression. Prescription of antidepressant drugs as the standard of care for depression warrants reconsideration. A biopsychosocial model may be more useful than a disease model for conceptualizing and treating depression.
ACCESSION #
45587386

 

Related Articles

  • Tailoring antidepressants to patients. Cowen, Philip // Pulse;9/29/2003, Vol. 63 Issue 39, p40 

    Focuses on issues related to the prescription of antidepressants in Great Britain. Efficacy in treating clinical depression; Controversy over suitable doses; Comparison between tricyclics and selective serotonin reuptake inhibitors.

  • The costs of pharmacological treatment for major depression. The Italian Prospective Multicentre Observational Incidence-Based Study. Tarricone, R.; Fattore, G.; Gerzeli, S.; Serra, G.; Taddei, C.; Percudani, M. // PharmacoEconomics;2000, Vol. 17 Issue 2, p167 

    Objective: To describe the pharmacological treatment for major depression under the conditions of routine Italian public mental health facilities, assess its costs, and study its main predictors according to a societal perspective.Design: This was a prospective...

  • Explaining the rise in antidepressent prescribing: a descriptive study using the general practice research database. Moore, Michael; Yuen, Ho Ming; Dunn, Nick; Mullee, Mark A.; Maskell, Joe; Kendrick, Tony // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;10/24/2009, Vol. 339 Issue 7727, p956 

    The article discusses a study which investigated the reasons for the increase in antidepressant prescribing in Great Britain. The researchers analyzed data from the general practice research database (GPRD), which include general practitioner consultations and antidepressant prescribing. The...

  • GPs desperate for depression options. Hairon, Nerys // Pulse;1/22/2005, Vol. 65 Issue 3, p18 

    Reports on the dilemma faced by general practitioners (GP) in deciding how to treat depressed patients in Great Britain. Avoidance of prescribing an antidepressants first line in mild depression; Decision of European Medicines Agency against the use of antidepressant in patients under 18 years...

  • GPs criticised for prescribing unnecessary antidepressants. Kelly, Brian // Pulse;9/1/2003, Vol. 63 Issue 35, p7 

    Reports on the prevalence of unnecessary prescription of antidepressants by physicians to mildly depressed patients in Great Britain. Preference of patients to counseling or cognitive behavioral therapy; Recommendation of adopting a watchful waiting approach by physicians; Reaction of...

  • Resultados de 6 años de terapia cognitivo-conductual para la prevención de la depresión recurrente. Fava, Giovanni A.; Ruini, Chiara; Rafanelli, Chiara; Finos, Livio; Conti, Sandra; Grandi, Silvana // American Journal of Psychiatry - Edición Española;Jan2005, Vol. 8 Issue 1, p31 

    No abstract available.

  • Adherence to Treatment to Prevent Depression Relapse. Kirchner, Jeffrey T. // American Family Physician;4/1/1999, Vol. 59 Issue 7, p1933 

    Presents an abstract of the study `The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression,' by C.A. Melfi et al., from the `Archives of General Psychiatry' dated December 1998.

  • Use SSRIs first-line says NICE.  // Pulse;9/22/2003, Vol. 63 Issue 38, p3 

    Reports on the recommendation for general practitioners to use SSRI, an antidepressant drug, for treating mental depression in Great Britain.

  • Desipramine.  // AHFS Consumer Medication Information;Sep2019, p1 

    Desipramine is used to treat depression. Desipramine is in a class of medications called tricyclic antidepressants. It works by increasing the amounts of certain natural substances in the brain that are needed for mental balance.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics